A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its ...

Since then, Dr. Nassiri and Inderbir Gill, MD, chair of the department of urology at USC Keck School of Medicine, had ...

This article was reviewed by Julia Switzer, MD, FACOG. Urinary incontinence is the term for a loss of bladder control. In ...

Following the positive outcome, Pfizer and Astellas will seek approval of Padcev-Keytruda in MIBC regardless of a patient’s ...

Men and women often experience similar bladder symptoms, but the causes are completely different. With insights from Dr ...

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer ...

A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...

Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as a perioperative therapy for ...

A diagnosis of adenocarcinoma of the bladder requires careful and specialized care. Because it is rare, it is essential to be treated by a multidisciplinary team, including a urologic oncologist, ...